Payer PolicyActive
SURG.00157 Minimally Invasive Treatment of the Posterior Nasal Nerve to Treat Rhinitis
ANTHEM-SURG.00157
Anthem
Effective: October 1, 2025
Updated: December 30, 2025
Policy Summary
Anthem SURG.00157 addresses minimally invasive posterior nasal nerve treatments—such as cryotherapy or radiofrequency ablation—used to manage symptoms of allergic, nonallergic, or mixed chronic rhinitis. These procedures are considered investigational and not medically necessary, and therefore are not covered for any indication. There are no covered exceptions; this applies across all rhinitis subtypes and related codes (for example, 30117, 30999, 31242, 31243, C9771).
Coverage Criteria Preview
Key requirements from the full policy
"Minimally invasive treatment of the posterior nasal nerve, such as cryotherapy or radiofrequency therapy, to decrease the symptoms of allergic or nonallergic rhinitis is consideredinvestigational a..."
Sign up to see full coverage criteria, indications, and limitations.